← Back to Search

Deep Brain Stimulation

Deep Brain Stimulation for Opioid Use Disorder (DBS_OUD Trial)

N/A
Waitlist Available
Led By Ali R Rezai, MD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 - 52 weeks
Awards & highlights

DBS_OUD Trial Summary

This trial is testing a new treatment for people with opioid addiction who haven't responded to other treatments. The goal is to see if it's safe and works better than other treatments.

DBS_OUD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 - 52 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 - 52 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Opioid Use
Incidence of Study-Emergent Adverse Events
Secondary outcome measures
Incidence of Serious Infectious Disease Complications
Mood, Craving and Executive Function
Participant Survival
+1 more
Other outcome measures
Changes in Dopamine
Frontal Lobe Metabolism

DBS_OUD Trial Design

1Treatment groups
Experimental Treatment
Group I: OUD DBSExperimental Treatment1 Intervention
This is a single arm study. Participants will be followed in an inpatient service for two weeks to gather baseline data followed by DBS placement and up to 6 weeks inpatient for clinical stabilization and DBS titration. All participants will then be followed twice a week for 12 weeks in the outpatient setting and then once a week for a total of 52 weeks post-titration.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,589 Total Patients Enrolled
West Virginia UniversityLead Sponsor
175 Previous Clinical Trials
56,302 Total Patients Enrolled
MedtronicIndustry Sponsor
605 Previous Clinical Trials
828,191 Total Patients Enrolled

Media Library

Deep Brain Stimulation (Deep Brain Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT03950492 — N/A
Opioid Use Disorder Clinical Trial 2023: Deep Brain Stimulation Highlights & Side Effects. Trial Name: NCT03950492 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Arizona
What site did they apply to?
West Virginia University Rockefeller Neuroscience Institute
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I've tried most available types of treatment with inpatient and outpatient with Suboxone multiple times and just feel I've exhausted all other options and desperate to try something new that may work to fix me or aid me into finally some relief after 13+ miserable years of no joy or pleasure or happiness. Please help.
PatientReceived 2+ prior treatments
~1 spots leftby Apr 2025